Synthesis of some new 3-[5-(2-oxo-2H-3-chromenyl)-1,3-oxazol-2-yl]-1,3-thiazolan-4-ones as antimicrobials

被引:5
作者
Reddy, Cherkupally Sanjeeva [1 ]
Rao, L. Sanjeeva [1 ]
Devi, M. Vani [1 ]
Kumar, G. Rajesh [1 ]
Nagaraj, A. [2 ]
机构
[1] Kakatiya Univ, Dept Chem, Warangal 506009, Andhra Pradesh, India
[2] Telangana Univ, Dept Pharmaceut Chem, Nizamabad 503175, India
关键词
1,3-Thiazolan-4-ones; 2-Oxo-2H-chromenyl; 1,3-Oxazolyl; Antibacterial activity; THIAZOLIDIN-4-ONES; INHIBITION; COUMARIN; CP-060S; ACID;
D O I
10.1016/j.cclet.2010.03.018
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A series of some new 2-imino-5-[(Z)-1-(4-methylphenyl)methylidene]-3-[5-(2-oxo-2H-3-chromenyl)-1,3-oxazol-2-yl]-1,3-thiazolan-4-ones 5a-j has been synthesized and assayed for their antibacterial activity against Gram-positive bacteria viz. Bacillus subtilis (ATCC 6633), Staphylococcus aureus (ATCC 6538p) and Micrococcus luteus (IFC 12708), and Gram-negative bacteria viz. Proteus vulgaris (ATCC 3851), Salmonella typhimurium (ATCC 14028) and Escherichia coli (ATCC 25922). Among the screened compounds, 5d, 5e, 5f, 5g, and 5j exhibited potent inhibitory activity compared to standard drug, and emerged as potential molecules for further development. (C) 2010 Cherkupally Sanjeeva Reddy. Published by Elsevier B.V. on behalf of Chinese Chemical Society. All rights reserved.
引用
收藏
页码:1045 / 1048
页数:4
相关论文
共 33 条
[1]   The anti-ischemic effects of CP-060S during pacing-induced ischemia in anesthetized dogs [J].
Adachi, Y ;
Suzuki, Y ;
Homma, N ;
Fukazawa, M ;
Tamura, K ;
Nishie, I ;
Kuromaru, O .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 367 (2-3) :267-273
[2]  
Chande MS, 2005, J CHEM RES, P345
[3]   An asymmetric approach to coumarin anticoagulants via hetero-Diels-Alder cycloaddition [J].
Cravotto, G ;
Nano, GM ;
Palmisano, G ;
Tagliapietra, S .
TETRAHEDRON-ASYMMETRY, 2001, 12 (05) :707-709
[4]  
Diurno MV, 1997, FARMACO, V52, P237
[5]   Synthesis and structure-activity relationships of 2-(substituted phenyl)-3-[3-(N,N-dimethylamino)propyl]-1,3-thiazolidin-4-ones acting as H1-histamine antagonists [J].
Diurno, MV ;
Mazzoni, O ;
Correale, G ;
Monterrey, IG ;
Calignano, A ;
La Rana, G ;
Bolognese, A .
FARMACO, 1999, 54 (09) :579-583
[6]   6-substituted 2-oxo-2H-1-benzopyran-3-carboxylic acid as a core structure for specific inhibitors of human leukocyte elastase [J].
Doucet, C ;
Pochet, L ;
Thierry, N ;
Pirotte, B ;
Delarge, J ;
Reboud-Ravaux, M .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (20) :4161-4171
[7]  
Ebeid M.Y., 1996, B FAC PHARM, V34, P125
[8]  
ERGENC N, 1994, FARMACO, V49, P449
[9]  
Geen G.R., 1996, Comprehensive heterocyclic chemistry II, V5, P469, DOI DOI 10.1016/B978-008096518-5.00112-X
[10]  
GRUNDY WE, 1952, ANTIBIOT CHEMOTHER, V2, P399